Galapagos announces BioFocus DPI's drug discovery collaboration with SPRI

Download PDF Copy

Sep 24 2009

Galapagos NV (Euronext: GLPG) announces today that its service division, BioFocus DPI, has initiated a drug discovery collaboration with Schering-Plough Research Institute (SPRI). Under the terms of the agreement, BioFocus DPI will perform medicinal chemistry with supporting biology and ADME/PK services for multiple Schering-Plough drug discovery projects. Total contract value for Galapagos is EUR 2.8 M over a one year period.

Building on a collaboration established in May 2009 and expanded this month, BioFocus DPI scientists will work with two of SPRI's European sites on these drug discovery projects.

"We are pleased to build on our collaborative relationship with SPRI, which has evolved into one of the larger for BioFocus DPI this year with over 20 research staff currently engaged," said Onno van de Stolpe, CEO of Galapagos. "BioFocus DPI has proven resilient in securing large collaborations with strong partners, amidst consolidation and reorganization in the pharma industry."

Source:

Galapagos NV

Posted in:

Comments (0)

Download PDF Copy

Suggested Reading

Advancing GPCR drug discovery with fragment screening using GCI technology

Optogenetic platform enables precise discovery of anti-aging therapeutics

Scaling organ‑chip technology for human‑relevant drug discovery

PhoreMost demonstrates new approach to rationalize molecular glue drug discovery

Solgate streamlines SLC drug discovery with INTEGRA's automated pipetting systems

New AI model can identify treatments that reverse disease states in cells

Advancing drug discovery with AI, generative chemistry, and 3D molecular design

Optibrium partners with TalTech on EU-funded PhD program to advance sustainable drug discovery

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.